Format
Sort by
Items per page

Send to

Choose Destination

Best matches for lymphangioleiomyomatosis AND tuberous sclerosis AND woman:

Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Cudzilo CJ et al. Chest. (2013)

Renal angiomyolipoma and lymphangioleiomyomatosis in pregnancy. Iruloh C et al. J Obstet Gynaecol. (2013)

Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment. Meraj R et al. Semin Respir Crit Care Med. (2012)

Search results

Items: 1 to 20 of 216

1.

The LAM Lung Cell and Its Human Cell Models.

Steagall WK, Pacheco-Rodriguez G, Darling TN, Torre O, Harari S, Moss J.

Am J Respir Cell Mol Biol. 2018 Feb 6. doi: 10.1165/rcmb.2017-0403TR. [Epub ahead of print]

PMID:
29406787
2.

Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation.

Garg K, Karnezis AN, Rabban JT.

Pathology. 2018 Feb;50(2):238-256. doi: 10.1016/j.pathol.2017.10.009. Epub 2018 Jan 17. Review.

PMID:
29373116
3.

Effect of beta-agonists on LAM progression and treatment.

Le K, Steagall WK, Stylianou M, Pacheco-Rodriguez G, Darling TN, Vaughan M, Moss J.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E944-E953. doi: 10.1073/pnas.1719960115. Epub 2018 Jan 16.

PMID:
29339522
4.

Fibrous Cephalic Plaques in Tuberous Sclerosis Complex.

Oyerinde O, Buccine D, Treichel A, Hong C, Lee CR, Moss J, Darling TN.

J Am Acad Dermatol. 2017 Dec 16. pii: S0190-9622(17)32858-X. doi: 10.1016/j.jaad.2017.12.027. [Epub ahead of print]

PMID:
29258863
5.

Emerging biomarkers of lymphangioleiomyomatosis.

Nijmeh J, El-Chemaly S, Henske EP.

Expert Rev Respir Med. 2018 Feb;12(2):95-102. doi: 10.1080/17476348.2018.1409622. Epub 2017 Dec 1.

PMID:
29171770
6.

Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.

Koba T, Arai T, Kitaichi M, Kasai T, Hirose M, Tachibana K, Sugimoto C, Akira M, Hayashi S, Inoue Y.

Respirology. 2018 Mar;23(3):331-338. doi: 10.1111/resp.13190. Epub 2017 Sep 28.

PMID:
28960664
7.

Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes.

Moh M, Sangoi AR, Rabban JT.

Hum Pathol. 2017 Oct;68:175-183. doi: 10.1016/j.humpath.2017.08.035. Epub 2017 Sep 9.

PMID:
28899738
8.

Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?

Di Marco F, Palumbo G, Terraneo S, Imeri G, Lesma E, Sverzellati N, Peron A, Gualandri L, Canevini MP, Centanni S.

BMC Pulm Med. 2017 Jul 28;17(1):107. doi: 10.1186/s12890-017-0447-x.

9.

[Pulmonary lymphangioleimyomatosis : review and case report].

Excoffier S, Guinand O, Rochat T.

Rev Med Suisse. 2016 Aug 24;12(527):1390-1393. French.

PMID:
28671794
10.

Renal Epithelioid Angiomyolipoma Associated with Pulmonary Lymphangioleiomyomatosis: Imaging Findings.

Tsili AC, Ntorkou A, Argyropoulou MI.

J Clin Imaging Sci. 2017 May 22;7:18. doi: 10.4103/jcis.JCIS_14_17. eCollection 2017.

11.

CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.

Glasgow CG, Pacheco-Rodriguez G, Steagall WK, Haughey ME, Julien-Williams PA, Stylianou MP, Gochuico BR, Moss J.

Chest. 2018 Feb;153(2):339-348. doi: 10.1016/j.chest.2017.05.018. Epub 2017 May 30.

PMID:
28576630
12.

Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.

Bongiorno MA, Nathan N, Oyerinde O, Wang JA, Lee CR, Brown GT, Moss J, Darling TN.

JAMA Dermatol. 2017 Jul 1;153(7):660-665. doi: 10.1001/jamadermatol.2017.0298.

PMID:
28445558
13.

Delayed Presentation of Tuberour Sclerosis Complex in Adult Women.

Manalac J, Sadd S, Akoghlanian G, Benoit-Clark T.

J La State Med Soc. 2017 Mar-Apr;169(2):46. Epub 2017 Apr 15.

PMID:
28414661
14.

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

Cui Y, Steagall WK, Lamattina AM, Pacheco-Rodriguez G, Stylianou M, Kidambi P, Stump B, Golzarri F, Rosas IO, Priolo C, Henske EP, Moss J, El-Chemaly S.

Cancer Res. 2017 Mar 15;77(6):1492-1502. doi: 10.1158/0008-5472.CAN-16-2755. Epub 2017 Feb 15.

PMID:
28202529
15.

Multifocal micronodular pneumocyte hyperplasia (MMPH) in a patient with tuberous sclerosis-evidence for long term stability.

Pannu BS, Apala DR, Kotecha A, Boland JM, Iyer VN.

Respir Med Case Rep. 2017 Jan 18;20:113-115. doi: 10.1016/j.rmcr.2017.01.010. eCollection 2017.

16.

EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.

Taveira-DaSilva AM, Moss J.

Expert Opin Orphan Drugs. 2016;4(4):369-378. Epub 2016 Mar 7.

17.

[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations].

Brakemeier S, Grohé C, Bachmann F, Budde K.

Pneumologie. 2017 Feb;71(2):86-95. doi: 10.1055/s-0042-111522. Epub 2016 Sep 1. Review. German. Erratum in: Pneumologie. 2017 Feb;71(2):e1.

PMID:
27585353
18.

Lymphangioleiomyomatosis.

Johnson SR, Taveira-DaSilva AM, Moss J.

Clin Chest Med. 2016 Sep;37(3):389-403. doi: 10.1016/j.ccm.2016.04.002. Review.

PMID:
27514586
19.

[Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].

Sobiecka M.

Wiad Lek. 2016;69(2 Pt 1):123-9. Polish.

PMID:
27421126
20.

Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Prizant H, Hammes SR.

Endocrinology. 2016 Sep;157(9):3374-83. doi: 10.1210/en.2016-1395. Epub 2016 Jul 13. Review.

Supplemental Content

Loading ...
Support Center